A PHASE I/II, DOSE-ESCALATION STUDY OFMGTA-117 IN PATIENTS WITH ADULT ACUTEMYELOID LEUKEMIA (AML) ANDMYELODYSPLASIA-EXCESS BLASTS (MDS-EB)

Project: Research project

Project Details

Description

A PHASE I/II, DOSE-ESCALATION STUDY OF MGTA-117 IN PATIENTS WITH ADULT ACUTE MYELOID LEUKEMIA (AML) AND MYELODYSPLASIA-EXCESS BLASTS (MDS-EB)
StatusActive
Effective start/end date5/27/21 → 4/30/26

Funding

  • MAGENTA THERAPEUTICS

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint